Please assess the completion status of the following clinical trial:

Trial Title: The Effect of Prolonged Multimodal Analgesic Regimen on Post Hospital Discharge Opioid Use and Pain Control After Primary Total Knee Arthroplasty

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patients undergoing unilateral primary TKA with underlying diagnosis of osteoarthritis.~* ASA I - III~* Spinal anesthesia~* All patients will have cemented total knee utilizing a medial parapatellar approach including patellar resurfacing. A tourniquet will be used in all cases~* Male and Female over 18 who are willing and able to provide informed consent~Exclusion Criteria:~* Opioid use within 3 months preoperatively~* Inability to take the protocol medications~* Anticoagulant other than aspirin~* Contraindication to regional anesthesia~* Non-english speaking~* ASA IV or greater~* Psychiatric or cognitive disorders~* Allergy/contraindications to protocol medications.~* Renal insufficiency with Cr \> 2.0 or hepatic failure~* General anesthesia~* Sensory/motor disorder involving the operative limb

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Opioid Regimen (Type: ACTIVE_COMPARATOR): Weeks 1-4~* Oxycodone 5 mg PRN q4h (30 tablets)~* Tramadol 50 mg PRN q6h (30 tablets)
- Multimodal pain regimen with PRN opioids (Type: EXPERIMENTAL): Weeks 1-4~* Tylenol 1000 mg q8h (standing)~* Meloxicam 15 mg qD (standing).~* Gabapentin 200 mg BID (with morning and evening Tylenol dose)~* Metaxalone 800mg PO TID (Tizanidine 2mg q8h if insurance coverage is not possible for metaxalone)~* Esomeprazole 20mg daily if not already on another H2 blocker or PPI~* Oxycodone 5 mg PRN q4h (30 tablets)~* Tramadol 50 mg PRN q6h (30 tablets)

Based on this trial design, predict the completion outcome and termination type (if applicable).